Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2002
03/21/2002WO2002022573A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
03/21/2002WO2002022177A2 High efficiency cardiac gene transfer
03/21/2002WO2002022176A1 Method of modulating neovascularization
03/21/2002WO2002022174A1 A novel cationic lipopolymer as biocompatible gene delivery agent
03/21/2002WO2002022169A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
03/21/2002WO2002022151A2 Use of glp-1 and flp-2 peptides for treatment of bone disorders
03/21/2002WO2002022149A1 Use of il-6r/il-6 chimera in huntington's disease
03/21/2002WO2002022080A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
03/21/2002WO2002021996A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
03/21/2002WO2002021925A1 Pest control system
03/21/2002WO2002002142B1 Papillomavirus vaccine
03/21/2002WO2002000927A8 Diagnosis of diseases associated with development by means of assessing their methylation status
03/21/2002WO2002000706A3 Antimicrobial peptides of the family of defensins, polynucleotides encoding said peptides, transformed vectors and organisms containing them
03/21/2002WO2001098324A8 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
03/21/2002WO2001096867A3 Method for identifying insulin mimics or antagonists
03/21/2002WO2001096388A8 Compositions and methods for the therapy and diagnosis of colon cancer
03/21/2002WO2001089705A3 System and method for manipulating magnetically responsive particles in fluid samples to collect dna or rna from a sample
03/21/2002WO2001087982A3 Immunotoxin fusion proteins and means for expression thereof
03/21/2002WO2001087039A3 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
03/21/2002WO2001085963A3 Modification of gene expression in transgenic plants
03/21/2002WO2001085929A3 Methods for forming recombined nucleic acids
03/21/2002WO2001085909A3 Development of plant based biological sensors and novel disease resistance strategies
03/21/2002WO2001085780A8 Nucleic acid binding polypeptides
03/21/2002WO2001083789A3 Transgenic plants with increased calcium stores
03/21/2002WO2001081567A3 Method for producing genomic libraries and genomic libraries produced therewith
03/21/2002WO2001079257A3 Multidrug resistance (mdr) efflux pump polypeptides
03/21/2002WO2001077376A8 Diagnosis of diseases associated with metastasis
03/21/2002WO2001077341A3 Mammalian heparanase
03/21/2002WO2001077164A8 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
03/21/2002WO2001077159A3 An endogenous ketogulonigenium plasmid
03/21/2002WO2001075090A3 Methyl methanesulfonate induces a more than hundred-fold up-regulation of cmv promoter activity
03/21/2002WO2001074902A3 Adenine binding g protein coupled receptors
03/21/2002WO2001073001A3 Establishment of cellular manipulations which enhance oligo-mediated gene targeting
03/21/2002WO2001072841A3 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
03/21/2002WO2001072840A3 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
03/21/2002WO2001068871A3 Human phospholipases and polynucleotides encoding the same
03/21/2002WO2001068870A3 S-adenosyl-l-methionine:phosphoethanolamine n-methyltransferase compositions and methods for modulating lipid biosynthesis in plants
03/21/2002WO2001068861A3 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF
03/21/2002WO2001068859A3 Il-17 receptor like molecules and uses thereof
03/21/2002WO2001068854A3 Fibroblast growth factor-like molecules and uses thereof
03/21/2002WO2001068818A3 Hcv ns2/3 fragments and uses thereof
03/21/2002WO2001068700A3 Regulation of human substance p-like g protein-coupled receptor
03/21/2002WO2001066771A3 Human serine protease
03/21/2002WO2001066763A3 23436, a human ubiquitin protease family member and uses thereof
03/21/2002WO2001066757A8 25934, a novel fatty acid desaturase and uses therefor
03/21/2002WO2001066748A3 Full length expressed human polynucleotides and the polypeptides they encode
03/21/2002WO2001066743A3 A potassium channel molecule and uses therefor
03/21/2002WO2001065509A3 Cellular telephone interactive wagering system
03/21/2002WO2001064928A3 Transgenic plants with increased seed yield, biomass and harvest index
03/21/2002WO2001064923A3 Vire2-mediated trans-membrane delivery systems
03/21/2002WO2001064919A3 18036, a novel calpain-like protease and uses thereof
03/21/2002WO2001064890A3 Novel defense induced genes and uses thereof
03/21/2002WO2001064863A3 A screening system to identify polynucleotides encoding cleavable n-terminal signal sequences
03/21/2002WO2001064851A3 32670, novel human phosphatidylserine synthase-like molecules and uses thereof
03/21/2002WO2001064837A3 β NETRIN AND USES THEREOF
03/21/2002WO2001062942A3 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS
03/21/2002WO2001062905A3 Integrin antagonists
03/21/2002WO2001062890A8 A process for generating genetically modified pearl millet through agrobacterium and biolistic transformation
03/21/2002WO2001062889A8 A process for generating cytoplasmic male sterile line in rice and other crops by rna editing
03/21/2002WO2001062725A3 Methods and compositions for inhibiting angiogenesis
03/21/2002WO2001060991A3 Human kinases
03/21/2002WO2001060990A3 Sphingosine kinases
03/21/2002WO2001058954A3 Trade molecules and uses related thereto
03/21/2002WO2001057221A3 Dsp-12 and dsp-13 dual-specificity phosphatases
03/21/2002WO2001055411A3 Human sulfatases
03/21/2002WO2001051638A3 Drug metabolizing enzymes
03/21/2002WO2001051604A3 Methods for identifying anti-cancer drug targets
03/21/2002WO2001051510A3 G-csf conjugates
03/21/2002WO2001049775A3 Antisense antibacterial cell division composition and method
03/21/2002WO2001048230A3 Modified dhps genes
03/21/2002WO2001047952A3 Insecticidal proteins from bacillus thuringiensis
03/21/2002WO2001042295A3 Clasp-7 transmembrane protein
03/21/2002WO2001040465A3 Compositions and methods for the treatment of immune related diseases
03/21/2002WO2001037779A3 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
03/21/2002WO2001036635A3 Neurite outgrowth-promoting factor homologue and nucleic acids encoding same
03/21/2002WO2001032872A3 Twik potassium channel molecules and uses therefor
03/21/2002WO2001032712A3 Antibody diversity generation
03/21/2002WO2001031041A3 Modification of plant architecture
03/21/2002WO2001031009A3 Chandra: a th1-specific gene
03/21/2002WO2001029232A3 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage
03/21/2002WO2001020039A3 Method of sequencing a nucleic acid
03/21/2002WO2001012855A3 Binary encoded sequence tags
03/21/2002WO2001010199A9 A knockout mouse for the tumor suppressor gene anx7
03/21/2002WO2000052208A3 Customized oligonucleotide microchips that convert multiple genetic information to simple patterns
03/21/2002US20020035740 Generating plants with intensified propagation characteristics; obtain cells, transform cells, monitor plastids of genetically engineered plant for preferential gene expression
03/21/2002US20020035739 Detecting disease resistant plants; obtain nucleic acid sample, express disease resistant genes, detect plant response
03/21/2002US20020035738 Plant protection method
03/21/2002US20020035737 Cloning pigs using donor nuclei from differentiated cells
03/21/2002US20020035736 HER2-transgenic non-human tumor model
03/21/2002US20020035735 Reproducing and animal; obtain preferential embryonic cells, culture cells, transfer cells to primate, recover infant
03/21/2002US20020035734 Binding protein for use in the treatment of neutropenia, infections and cancer
03/21/2002US20020035733 Congenic animal models of non-insulin dependent diabetes mellitus
03/21/2002US20020035249 Production of exopolysaccharides unattached to the surface of bacterial cells
03/21/2002US20020035246 SMAD-interacting polypeptides and their use
03/21/2002US20020035245 Recombinant vanadium haloperoxidases and their uses
03/21/2002US20020035242 Antibody binding
03/21/2002US20020035240 Novel mammalian cell cycle protein
03/21/2002US20020035083 CRF2 ligands in combination therapy
03/21/2002US20020035082 Lipids where the glycerol backbone is replaced with a carbohydrate; conjugates; drug delivery
03/21/2002US20020035081 Nucleic acid encoding a polypeptide of the virus' core protein having altered carboxyterminus, for reducing replication of a wild type hepadnavirus, by a dominant negative mechanism
1 ... 2854 2855 2856 2857 2858 2859 2860 2861 2862 2863 2864 2865 2866 2867 2868 2869 2870 2871 2872 2873 2874 ... 4023